Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Moolec Science ( (MLEC) ) has shared an announcement.
On November 24, 2025, Moolec Science received a notification from Nasdaq indicating non-compliance with the requirement to file its Annual Report on Form 20-F for the year ended June 30, 2025. This delay stems from complexities following a business combination in mid-June 2025, involving intricate accounting and valuation processes. Moolec has requested a stay of suspension, allowing its shares to continue trading on Nasdaq until a hearing scheduled for December 18, 2025. The company is actively working to complete the filing before the hearing, aiming to maintain its Nasdaq listing.
The most recent analyst rating on (MLEC) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Underperform.
Moolec Science faces significant financial challenges with negative profitability and cash flow issues despite revenue growth. The technical analysis is bearish, and the valuation appears unfavorable with a negative P/E ratio. These factors contribute to a low overall stock score, highlighting the need for improved financial performance and market sentiment.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science is an innovation-driven company that engineers plants and microbes to create scalable protein solutions for the global food system. By integrating Molecular Farming and precision fermentation, Moolec combines the cost efficiency of crops with the functionality and nutrition of animal proteins, offering sustainable and commercially viable ingredients. The company’s pipeline includes alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture. Moolec holds a robust intellectual property portfolio with over 118 granted and pending patents across multiple technology platforms and operates in the United States, Europe, and South America. The company is publicly listed on Nasdaq under the ticker ‘MLEC.’
Average Trading Volume: 150,525
Technical Sentiment Signal: Sell
Current Market Cap: $4.46M
For detailed information about MLEC stock, go to TipRanks’ Stock Analysis page.